https://www.selleckchem.com/products/yum70.html
05) in the PVRP group. No statistically significant differences in CPTBCI foci surface area were detected between checkups in the control group ( = 0.152). Nine patients from the PVRP group and three patients from the control group were CPTBCI symptom-free at the fourth checkup. The median symptom-free time was 9.2 months (95% CI [7.4, 11.9]) in the PVRP group. Cumulatively, 49% of patients in the PVRP group remained CPTBCI symptom-free for 12.7 months after the fourth checkup. Autologous PVRP represents a novel additional and successful
Like
Comment
Share
